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Abstract
Recent advances in DNA sequencing have enabled mapping of genes for monogenic traits in families with small pedigrees
and even in unrelated cases. We report the identification of disease-causing mutations in a rare, severe, skeletal dysplasia,
studying a family of two healthy unrelated parents and two affected children using whole-exome sequencing. The two
affected daughters have clinical and radiographic features suggestive of anauxetic dysplasia (OMIM 607095), a rare form of
dwarfism caused by mutations of RMRP. However, mutations of RMRP were excluded in this family by direct sequencing.
Our studies identified two novel compound heterozygous loss-of-function mutations in POP1, which encodes a core
component of the RNase mitochondrial RNA processing (RNase MRP) complex that directly interacts with the RMRP RNA
domains that are affected in anauxetic dysplasia. We demonstrate that these mutations impair the integrity and activity of
this complex and that they impair cell proliferation, providing likely molecular and cellular mechanisms by which POP1
mutations cause this severe skeletal dysplasia.
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Introduction
Skeletal dysplasias (SD) are a group of genetic disorders
affecting skeletal development that cause deficiencies and
deformities of the limbs and spine, dwarfism, or abnormal bone
strength. SDs are usually inherited as dominant or recessive
monogenic Mendelian traits or occur as a result of de novo
mutations. Recent advanced in targeted whole-exome DNA re-
sequencing have enabled several groups to identify of causative
mutations underlying various Mendelian diseases, in which
traditional linkage approaches were not feasible because of the
paucity of familial cases in which to perform the mapping [1–7]. In
this study we report the mapping of mutations causing a severe
bone dysplasia in a family of unrelated unaffected parents with two
affected siblings. The clinical and radiographic features of the
affected siblings showed similarities to anauxetic dysplasia, an
autosomal recessive spondylo-epi-metaphyseal dysplasia charac-
terized by extremely short stature [8,9]. Both siblings had severe
growth retardation of prenatal onset, a bone dysplasia affecting the
epiphyses and metaphyses of the long bones particularly in the
lower limbs, and abnormalities of the spine including irregularly
shaped vertebral bodies and marked cervical spine instability
(Figure 1). Anauxetic dysplasia is caused by mutations in RMRP,
an untranslated intronless gene, mutations of which also cause
cartilage-hair hypoplasia (CHH, OMIM 250250), another severe
form of dwarfism [10]. As RMRP mutations had been excluded in
this family, we sought to identify the disease-causing variants by
whole-exome sequencing.
Results/Discussion
We sequenced exomes of both parents and the affected siblings
using the Nimblegen SeqCap Ez exome capture protocol and the
Illumina Genome Analyser II paired-end sequencing method.
High quality sequence reads were aligned to the human reference
genome (UCSC assembly hg19); 90% of targeted bases had
coverage of fourfold or higher; and 79% of targeted bases had
coverage greater than tenfold. We then used SAMtools [11],
Genome Analysis Toolkit (GATK) [12] and custom scripts to
detect polymorphic sites in the four individual exome sequence
data sets. Following quality filtering, we retained approximately
15,000 SNPs per sequenced exome (Table 1). The vast majority of
these SNPs (.96%) were reported in the recent NCBI dbSNP 131
release, and were therefore excluded from further analysis as
unlikely to cause this severe, rare, phenotype. Following the
functional annotation of the remaining novel SNPs, we focused
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our analyses on a set of 483 unique novel coding non-synonymous
SNPs that were detected in at least one sample.
Given the affected status of both siblings and unaffected status of
the parents we considered autosomal recessive homozygous and
autosomal recessive compound heterozygous as the two most likely
inheritance models; as the parents are unrelated, a compound
heterozygous model was considered most likely. All novel non-
synonymous SNPs were analyzed assuming either a homozygous
or a compound heterozygous model. We did not find any novel
non-synonymous mutations that satisfied a recessive homozygous
inheritance model. To be accepted as candidate mutations for a
compound heterozygous inheritance model, we sought genes with
at least two novel non-synonymous SNPs within the protein
coding sequence in both siblings; additionally, the same alleles had
to be present in the parents in a mutually exclusive manner. We
identified four candidate genes (POP1, PKD1, MICALL2, and
COL5A1) that fitted this model (Table S1).
To determine the gene likely to be causing the disease we
analyzed the effects of the detected missense mutations on protein
function using the SIFT algorithm [13]. In all but one gene the
detected missense mutations were predicted to be tolerated in
terms of effect upon protein function. The single remaining
candidate gene carried two novel alleles – one creating a
premature stop codon, and the other causing a missense mutation
with predicted damaging effect on protein function, thus
representing a strong candidate for the disease-causing gene in
this family (Figure 2). Remarkably, we found that this gene
encodes the human homolog of the yeast POP1 (processing of
precursor RNA) protein, one of the core components of the RNase
P and RNase MRP complexes [14,15].
RNase P and RNase MRP are essential ribonucleoprotein
complexes present in all eukaryotes [16]. Both enzymatic
complexes have an evolutionarily conserved RNA component as
a catalytic moiety. Several proteins essential for enzymatic activity
form a constitutive part of RNAse P and RNase MRP complexes.
POP1 is the largest constitutive component of both complexes
(Figure S1) [15,16]. Importantly, mutations in RMRP, which
encodes the RNA moiety of the RNase MRP complex, cause
anauxetic dysplasia and cartilage-hair hypoplasia [10].
To validate the identified POP1 mutations we re-sequenced
genomic DNA fragments encompassing mutated alleles of the
POP1 gene using Sanger sequencing, confirming that the two
affected siblings carry both mutated alleles, while each parent
carries only one allele (Figure 2A, 2B). While neither of these
mutations is located within known protein domains (as determined
by PFAM annotation), both amino acids affected by the mutations
show high levels of evolutionary conservation, suggesting their
importance for the functional integrity of POP1 and/or RNase P/
RNase MRP complexes (Figure 2C; Figure S1). The p.Arg513Ter
mutation is likely to be particularly damaging; the premature stop
codon located in the exon 10 would trigger mRNA degradation
via nonsense mediated decay mechanism. Alternatively (though
less likely), p.Arg513Ter mutation would result in translation of a
truncated protein lacking the evolutionarily conserved POPLD
domain (Figure 2C). These results are consistent with findings in
yeast. Xiao et al. [16] identified several point mutations in the
yeast POP1 protein that affect either the stability or activity of
RNase P and RNase MRP complexes. Importantly, some of the
yeast mutations were found close to the mutations identified in our
study, supporting our conclusion that these are likely to cause
significant detrimental effect on RNase P and RNase RMP
function.
The very low population frequency of the described skeletal
dysplasia, and the essential roles of RNase P/RNase MRP
enzymatic complexes in cellular functions, suggest that there is
strong negative selection pressure on homozygous and compound
heterozygous mutations with detrimental effects on the activity of
these complexes. Indeed, analysis of mutations that ablate POP1
function in model organisms demonstrate that POP1 is essential
for viability in yeast and Drosophila [14,17]. In this context, it is
likely that one or both detected POP1 mutations have only a
partial effect on function of either RNAse P or RNase MRP
complexes. This conclusion is consistent with the broad spectrum
of mutations observed in RMRP in cases of anauxetic dysplasia and
cartilage-hair hypoplasia and their correlation with the severity of
the disease phenotype [18]. RMRP mutations implicated in
anauxetic dysplasia and cartilage-hair hypoplasia have distinct
clustering within the RMRP RNA molecule [18]. Importantly,
POP1 directly interacts with the same RMRP RNA domains that
are affected in anauxetic dysplasia (Figure S1) [18,19]. This further
strengthens the link between our findings and the molecular
mechanisms underlying the clinical phenotype in anauxetic
dysplasia and our patients.
To assess population frequency of the POP1 alleles we screened
186 DNA samples from healthy control subjects. For the
NM_001145860.1:c.1573C.T (p.Arg513Ter) allele we used
direct Sanger sequencing of PCR-amplified DNA fragments. To
estimate the frequency of the second POP1 allele,
NM_001145860.1:c.1748G.A (p.Gly583Glu), we used a restric-
tion fragment length polymorphism (RFLP) assay designed to
detect the loss of the BsaJ1 restriction site (CCNNGG) created by
c.1748G.A (p.Gly583Glu) mutation. None of the 186 control
samples contained either mutation. Further, these variants are not
reported in public SNP databases including dbSNP 131.
Therefore we conclude that both mutations represent novel rare
alleles.
One of the cellular functions of the RNase RMP complex is
processing of precursor 5.8S ribosomal RNA into the mature form
[15]. To determine the impact of the mutated alleles on functional
integrity and activity of the RNase P/MRP complexes, we
measured relative abundance of the RMRP RNA and unprocessed
pre-5.8S rRNA in the affected siblings, non-affected parents, and
unrelated controls. We found that the relative abundance of
RMRP RNA was markedly reduced in the affected individuals
compared with non-affected parents and controls (Figure 3),
indicating that the mutated alleles are likely to cause mis-assembly
and destabilization of the RNase MRP complex. These results are
consistent with the previous study in yeast demonstrating that
mutations in POP1 affect integrity of the RNase MRP complex,
resulting in destabilization of the complex and reduction of the
abundance of NME1 RNA (the yeast homolog of human RMRP)
Author Summary
Skeletal dysplasias are a group of genetic disorders
affecting skeletal development that cause deficiencies
and deformities of the limbs and spine, dwarfism, or
abnormal bone strength. Skeletal dysplasias are usually
inherited as monogenic Mendelian traits or occur as a
result of de novo mutations. We report identification of
mutations in human POP1 gene as the cause of a severe
novel skeletal dysplasia. Molecular analyses presented in
our work provide an important link between the
pathogenesis of the disease and basic cellular processes
including RNA processing and the cell cycle. We posit that
our work will also have an immediate impact on
assessment and counselling of novel cases of severe short
stature.
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Table 1. SNPs detected in four exomes.
Sample # Total SNPs # Filtered SNPs # SNPs in dbSNP131 (%*) # Novel non-synonymous SNPs
SKDP 6.1 17,108 14,868 14,410 (96.9) 227
SKDP 6.2 17,110 14,949 14,451 (96.7) 216
SKDP 6.3 17,284 15,306 14,822 (96.8) 248
SKDP 6.4 17,142 14,566 14,112 (96.9) 224
doi:10.1371/journal.pgen.1002027.t001
Figure 1. Radiographs of patient 1 at 13 months of age. (A) J-shaped sella. (B) The tubular bones in the hand are short and show metaphyseal
irregularities. (C) The iliac bodies are hypoplastic with slanting acetabular roofs. The capital femoral epiphyses are unossified and the femoral necks
are hypoplastic and in varus position. The pubic bones are thin. (D) The vertebral bodies are ovoid with dorsal wedging. (E) Metaphyseal irregularities
at the knee and ankle, the metaphysis of the distal tibia is delta-shaped.
doi:10.1371/journal.pgen.1002027.g001
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[16]. We also found that affected individuals have higher
abundance of the unprocessed pre-5.8S rRNA compared to
non-affected parents and controls (Figure 3), consistent with the
established role of RNase P in processing of rRNA [15] and
demonstrating that activity of the RNAse MRP complex is
impaired in the affected individuals. To assess the cellular impact
of this molecular defect, we measured cell proliferation in
stimulated peripheral blood mononuclear cells (Figure 4). These
studies showed that, in comparison with healthy controls, the two
affected cases had markedly diminished cell proliferation in
response to proliferation stimulus, as evidenced by the reduced
rate of dilution of CFSE fluorescence intensities (Figure 4A).
Additionally, individual SKDP-6.1, carrying the c.1573C.T
(p.Arg513Ter) allele, had noticeable reduction in cell proliferation
rate, consistent with the predicted more damaging effect of this
mutation (Figure 4). These findings also explain similarities with
the anauxetic dysplasia phenotype, as individuals with this disease
also have impaired RNase P/RNase MRP activity, and dimin-
ished cell turnover [10,18].
In conclusion, we have identified mutations in POP1 underlying
the skeletal dysplasia presented in this study. Involvement of POP1
in the skeletal dysplasia highlighted the existence of a shared
molecular pathway in the etiology of skeletal dysplasias involving
the RNAse P and RNase MRP complexes [10,18] and raises the
possibility of the involvement of other components of the pathway,
or allelic variants of RMRP or POP1, in other as yet unmapped
severe short-stature syndromes. Screening of RMRP-negative cases
of anauxetic dysplasia or CHH, or patients with similar
phenotypic features, may yield additional mutated alleles within
POP1, and possibly in other components of the RNase MRP
complex. We further hypothesize that the distinct skeletal
phenotype associated with POP1 mutations may indicate that
RNAse P and RNase MRP complexes may process other yet
unidentified target RNAs with regulatory roles in specific
developmental pathways such as osteogenesis. This study also
provides an example of the feasibility of whole-exome re-
sequencing approach in rare familiar monogenic diseases with
small pedigrees.
Materials and Methods
Human Subjects
This study was approved by the University of Queensland ethics
committee (Approval #2007001196). Written, informed, consent
was obtained from all subjects or their respective guardians.
Construction of DNA Libraries and Sequencing
5 mg of human genomic DNA extracted from peripheral venous
blood samples was used for preparation of each DNA sequencing
library. The DNA libraries were prepared using Illumina’s paired-
end sequencing DNA sample preparation kit according to the
manufacturer’s protocol.
Whole-exome sequence capture was performed using ‘‘SeqCap
EZ Exome Library v1.0’’ liquid phase sequence capture kit (Roche/
Figure 2. Mutations in the POP1 gene. (A) Pedigree of the studied
family. (B) SKDP-6.1 and SKDP-6.2 indicate sequences from non-affected
parents. SKDP-6.3 and SKDP-6.4 indicate sequences from two affected
siblings. Black arrowheads show positions of the mutated alleles.
Heterozygous nucleotide and amino acid substitutions are shown at the
top. Presence of the mutated alleles is indicated by red asterisks. (C) The
diagram shows scaled drawing of the POP1 gene intron-exon structure
(top) and the domain structure of POP1 protein; relative positions of
mutations indicated by red asterisks. The lower part of the diagram
shows fragments of multiple sequence alignments from UCSC genome
browser demonstrating high level of evolutionarily conservation of
amino acids affected by the mutations; the affected amino acids,
arginine (R) and glycine (G) are highlighted in red.
doi:10.1371/journal.pgen.1002027.g002
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Nimblegen) according to the manufacturer’s recommendations.
Sequence capture efficiency was assessed by quantitative real-time
PCR using a standard set of control primers recommended in the
sequence capture protocol. Individual DNA libraries were quality-
checked and quantified on Agilent 2100 Bioanalyzer using
DNA1000 kit, and DNA concentration adjusted to 10 nM.
Sequencing was performed on the Illumina Genome Analyzer
II using a standard 56 cycle paired-end read sequencing protocol
Figure 3. Relative abundance of pre-5.8S rRNA and RMRP RNA in the affected individuals. The relative abundance of the steady-state pre-
5.8S rRNA and RMRP RNA was determined by the real-time PCR using comparative CT method and human beta actin mRNA as an internal
normalization standard. Left side of the panel shows relative abundance of pre-5.8S rRNA in the affected individuals (SKDP-6.3, SKDP-6.4, black bars),
non-affected parents (SKDP-6.1, SKDP-6.2, grey bars), and unrelated healthy controls (CNTRL-1 - CNTRL-4, open bars). Right side of the panel shows
relative abundance of the RMRP RNA in the affected individuals (SKDP-6.3, SKDP-6.4, black bars), non-affected parents (SKDP-6.1, SKDP-6.2, grey bars),
and unrelated healthy controls (CNTRL-1 - CNTRL-4, open bars).
doi:10.1371/journal.pgen.1002027.g003
Figure 4. Proliferation rates of stimulated peripheral blood mononuclear cells. PBMC were labeled with CFSE and stimulated in vitro with
PMA and Ionomycin for 7 days. Cell division was assessed by examining rate of dilution of CFSE using flow cytometry. Affected individuals (SKDP-6.3,
SKDP-6.4), unaffected parents (SKDP-6.1, SKDP-6.2), and unrelated healthy controls (CNTRL-1 - CNTRL-4) are shown. (A) Representative FACS plots for
each sample showing rate of dilution of CFSE in response to stimulation (black lines). Affected individuals show marked reduction in proliferation
activity as demonstrated by the reduced rate of dilution of CFSE fluorescence intensities. Solid grey peaks represent unstimulated PBMC controls. (B)
Proliferation indices were calculated based on CSFE FACS data for cells undergoing 2 or more cell divisions using ModFit software.
doi:10.1371/journal.pgen.1002027.g004
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and Illumina’s sequencing reagents according to the manufactur-
er’s recommendations. Each library was sequenced individually on
a single flow cell lane.
Analysis of Sequencing Data
Base calling and sequence reads quality assessment was
performed using Illumina’s Data Analysis Pipeline software
v.1.6. Alignment of sequence reads to the reference human
genome (hg19, UCSC assembly, February 2009) was performed
using the Burrows-Wheeler alignment (BWA) tool [20]. Sequence
alignment files conversions were performed using SAMtools [11].
Only high quality sequence reads with unique mapping positions
to the reference human genome were used for calling SNPs and
Indels. Identification of SNPs and Indels in the alignment files
was performed using Genome Analysis Toolkit (GATK) [12]. Raw
SNP calls were filtered using empirically derived cut-offs
for the following GATK filter expressions: –filterExpression
‘‘QUAL ,50.0 || AB.0.75 && DP.40 || QD,5.0 ||
HRun.5 || SB.20.10’’ –filterName ‘‘StandardFilters’’ –filter-
Expression ‘‘DP,6’’ –filterName ‘‘LOW_DEPTH’’, where
QUAL – combined recalibrated quality score at the SNP position;
AB – allele balance at the SNP position; DP – sequencing depth at
the SNP position; QD – QUAL/DP ratio at the SNP position;
HRun – maximal length of the homopolymer run; SB- strand bias
at the SNP position. Known SNPs were obtained from the NCBI
dbSNP build 131 (http://www.ncbi.nlm.nih.gov/SNP/). Predic-
tion of the effect of non-synonymous amino acid substitutions on
protein function was done using SIFT algorithm [13].
Sanger Sequencing
Sanger sequencing of the exons 10 and 12 of POP1 was
performed on Genetic Analyzer 3130 (Applied Biosystems) using
standard sequencing protocol for PCR-amplified DNA. Primers
used for PCR amplification of POP1 DNA fragments and Sanger
sequencing were as follows: POP1.10F 59-CAATGGGAAGA-
GAGGGAATACATGTTT-39; POP1.10R 59-CTGGAGAGGT-
GTCAGAGAAAGAACTCTT-39; POP1.12F 59-CATCCTT-
GAGAAGGTGTCACTTAATTGTT-39; POP1.12R 59-CAC-
CACTCAATTCCTCCTAAGTTGTACAT-3.
186 DNA samples from healthy white European controls were
studied to determine the population frequency of the variants
identified. The c.1573C.T (p.Arg513Ter) allele located within
exon 10 of POP1 was tested by Sanger sequencing using POP1.10F
and POP1.10R primers listed above. The c.1748G.A (p.Gly583-
Glu) allele located within exon 12 of POP1was tested by a restriction
fragment length polymorphism (RFLP) assay designed to screen for
the loss of the BsaJ1 restriction site (CCNNGG) created by the
mutation. Following PCR amplification of exon 12 DNA fragments
with POP1.12F and POP1.12R primers, DNA fragments were
digested with BsaJ1, separated by agarose gel electrophoresis, and
visualised by ethidium bromide staining and UV transillumination.
RNA Isolation and cDNA Synthesis
Total RNA was extracted from peripheral blood mononuclear
cell samples using TRIZOL reagent (Invitrogen) following the
manufacturer’s protocol. The RNA concentrations and purity
were determined using the RNA 6000 Bioanalyzer kit (Agilent).
For cDNA synthesis, 500 ng of total RNA was treated with DNase
I (Invitrogen) and then utilized as a template for randomly primed
reverse transcription using SuperScript III reverse transcriptase
(Invitrogen), according to the manufacturer’s instructions. The
resulting cDNA was diluted 1:25 (v/v) with nuclease-free water. A
total of 5 mL of the cDNA was used as a template for quantitative
real-time PCR.
Quantitative Real-Time PCR
Relative abundance of unprocessed 5.8S rRNA and RMRP
transcripts in affected in non-affected individuals was determined
by real-time PCR using SYBR Green RCR Master Mix (Applied
Biosystems) according to manufacturer’s protocol. The PCR
amplification was performed on the ABI Prism 7900HT
sequence-detection system (Applied Biosystems) in a final volume
of 12 mL using standard cycling parameters (10 min, 95uC; 30 sec,
95uC; 30 sec 65uC; 30 sec 72uC, with the latter three steps
repeated for 45 times). Primers for the real-time PCR reaction
were designed using Vector NTI 11.0 software package (Invitro-
gen), following primer design guidelines given in the SYBR green
PCR Master Mix and RT-PCR protocol (Applied Biosystems).
The melting temperatures of all primers were between 65 and
71uC. All primers were purchased from the ITD (Glycon Australia
Pty Ltd).
The primers used for detection of pre-5.8S rRNA were as
follows: pre5.8S_F 59-TGTGAAACCTTCCGACCCCTCT-39;
pre5.8S_R 59-CGAGTGATCCACCGCTAAGAGTCGTA-39.
The primers used for detection of the RMRP RNA (GenBank
NR_003051) were as follows: RMRP_F 59-AGGACTCTGTTC-
CTCCCCTTTCCGCCTA-39, RMRP_R 59-TGGAGTGGGA-
AGCGGGGAATGTCTA-39.
The primers used for detection of human beta actin mRNA
(ACTB, GenBank NM_001101) used as an internal normalization
standard were as follows: ActF 59-TCACCATTGGCAATG-
AGCGGTT-39; ActR 59-AGTTTCGTGGATGCCACAGGA-
CT-39.
The final optimized concentration of primers was 250 nM for
all DNA amplicons. The absence of inter- and/or intramolecular
duplex formation between primers was confirmed in a control
real-time PCR reaction lacking template. Relative quantification
was performed as described in ABI Prism 7900HT Sequence
Detection System User Bulletin #2 (Applied Biosystems) accord-
ing to Comparative CT Method. In brief, threshold cycle (CT)
values of experimental samples were normalized to corresponding
CT values of the ACTB mRNA control, and then quantified
relative to the sample with the maximal CT value (calibrator). All
real-time PCR reactions were done in five technical replicates, and
results were confirmed in two independent experiments.
Cell Turnover Studies
Progressive dilution of the fluorescent dye CFSE during cell
division was used as a proxy to assess cell division rates using flow
cytometry [21]. PBMC from the affected children (SKDP 6.3 and
6.4), their parents (SKDP 6.1 and 6.2) and healthy controls were
labelled with 2.5 mMCFSE and plated in triplicate at 56105 cells/
well in 48-well plates. PBMC were stimulated with PMA and
Ionomycin or left unstimulated for seven days. Proliferation of
PBMC in response to stimulation was assessed by examining
CFSE dilution on a FACSCanto flow cytometer (BD). Compar-
ative cell division rates were determined by calculating prolifer-
ation indices of cells undergoing 2 or more cell divisions using
ModFit software (Verity Software House).
Accession Numbers
POP1 amino acid substitutions are given using human POP1
mRNA sequence and annotations with GenBank accession
NM_001145860. Human beta actin mRNA, RMRP RNA, and
rRNA polycistron sequences have GenBank accession numbers
NM_001101, NR_003051, and U13369 respectively. NCBI and
FlyBase accession numbers for Drosophila POP1 homolog are
NP_572236 and FBgn0026702 respectively.
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Web Resources
UCSC genome browser http://genome.ucsc.edu/; NCBI
dbSNP http://www.ncbi.nlm.nih.gov/SNP/; Protein families
database (PFAM) http://pfam.sanger.ac.uk/; SIFT website
http://sift.jcvi.org/; GATK website http://www.broadinstitute.
org/gsa/wiki/index.php/The_Genome_Analysis_Toolkit; Online
Mendelian Inheritance in Man (OMIM), http://www.ncbi.nlm.
nih.gov/Omim/.
Supporting Information
Figure S1 Structure of the RNase MRP complex (modified from
Welting et al, reproduced with permission of the Oxford
University Press). Human POP1 (hPOP1) highlighted in orange.
Domains of RMRP RNA that have been implicated in anauxetic
dysplasia highlighted in blue.
(PDF)
Table S1 Candidate mutations fitting compound heterozygous
model. SKDP 6.1 is the father, SKDP the mother, and SKDP 6.3
and 6.4 the affected children.
(PDF)
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